Abstract 205: Etiologic Ischemic Stroke Phenotypes in the NINDS Stroke Genetics Network
Background and Purpose: NINDS Stroke Genetics Network (SiGN) is an international consortium of ischemic stroke studies that aims to generate high quality phenotype data to identify the genetic basis of ischemic stroke subtypes. The goal of this analysis is to characterize the etiopathogenetic basis of ischemic stroke in the consortium.
Methods: This analysis included 16,954 subjects with imaging-confirmed ischemic stroke from 12 US studies and 11 studies from 8 European countries. 52 trained and certified adjudicators used the web-based Causative Classification of Stroke System for etiologic stroke classification through chart reviews to determine both phenotypic (abnormal test findings categorized in major etiologic groups without weighting towards the most likely cause in the presence of multiple etiologies) and causative subtypes in each subject. Classification reliability was assessed with blinded re-adjudication of 1509 randomly selected cases.
Findings: The figure shows the distribution of etiologic categories. Overall, only 40% to 54% of cases with a given major ischemic stroke etiology (phenotypic subtype) were classified into the same final causative category with high confidence. There was good agreement for both causative (kappa 0·72, 95%CI:0·69-0·75) and phenotypic classifications (kappa 0·73, 95%CI:0·70-0·75).
Conclusions: This study provides high quality data on etiologic stroke subtypes and demonstrates that etiologic subtypes can be determined with good reliability in studies that include investigators with different expertise and background, institutions with different stroke evaluation protocols and geographic location, and patient populations with different epidemiological characteristics. The discordance between phenotypic and causative stroke subtypes suggests that the presence of an abnormality in a stroke patient does not necessarily mean that it is the cause of stroke.
Author Disclosures: H. Ay: Research Grant; Significant; NIH R01-NS059710. E.M. Arsava: None. R. Brown: None. S.J. Kittner: Research Grant; Significant; NIH U01-NS069208. J. Lee: Research Grant; Significant; NIH R01-NS085419, R01-NS084028, R21-NS082529. P.F. McArdle: None. K.M. Rexrode: Research Grant; Significant; NIH U01-NS069208, R01-HL088521 . J. Rosand: Research Grant; Significant; NIH. Consultant/Advisory Board; Significant; Boehringer Ingelheim. T. Rundek: Research Grant; Significant; NIH K24-NS062737, R01-NS065114, U54-NS081763. A. Slowik: None. B.B. Worrall: Research Grant; Significant; NIH U01-NS069208. J.F. Meschia: Research Grant; Significant; NIH U01-NS069208, U01-NS080168.
- © 2015 by American Heart Association, Inc.